Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Enhancement of mdr1 gene expression by transforming growth factor-β1 in the new adriamycin-resistant human leukemia cell line ME-F2/ADM

Leukemia volume 11, pages 894–895 (1997)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Ehime University School of Medicine, Shigenobu, 791-02, Ehime, Japan

    Y Utsunomiya, H Hasegawa, K Yanagisawa & S Fujita

Authors
  1. Y Utsunomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Yanagisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Utsunomiya, Y., Hasegawa, H., Yanagisawa, K. et al. Enhancement of mdr1 gene expression by transforming growth factor-β1 in the new adriamycin-resistant human leukemia cell line ME-F2/ADM. Leukemia 11, 894–895 (1997). https://doi.org/10.1038/sj.leu.2400663

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2400663

This article is cited by

Search

Advanced search

Quick links